A Phase I, open-label, dose escalation study of MGA271 in combination with pembrolizumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck, or squamous cell non-smal…

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 12 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

Application EP-3359192-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.